MEXICO CITY, Dec 17 (Reuters) – The Mexican government hopes to finalize a contract with China's CanSino Biologics Inc for a first batch of COVID-19 vaccine doses next week, a top health ministry official said on Thursday, as the search for vaccine supplies heated up globally.
Deputy Health Minister Hugo Lopez-Gatell, the government's most prominent pandemic response official, told W Radio that the amount of vaccines Mexico aims to supply with the CanSino (6185.HK) contract is between 10 and 35 million doses.
The range contrasts with figures given by Mexican Foreign Minister Marcelo Ebrard last week when hesaid the health ministry had signed an agreement to buy 35 million doses of CanSino's vaccine, potentially floating the possibility of acquiring far fewer doses that originally planned. read more
Mexico has been especially hard-hit by the pandemic.
The government's official count shows that fatalities due to the coronavirus surpassed 115,000 on Wednesday, the fourth highest death toll worldwide behind only the United States, Brazil and India. read more
Our Standards: The Thomson Reuters Trust Principles.
Merck & Co's COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved
